DOI QR코드

DOI QR Code

The Effects of Injinsaryung-san on Rat with Alcoholic Fatty Liver

인진사령산(茵蔯四苓散)이 흰쥐의 알콜성 지방간에 미치는 영향

  • Kim, Bum Hoi (Department of Anatomy, College of Korean Medicine and Research Institute of Oriental Medicine, Dong-eui University)
  • 김범회 (동의대학교 한의과대학 한의학과, 동의대학교 한의학연구소)
  • Received : 2018.04.18
  • Accepted : 2018.05.25
  • Published : 2018.05.31

Abstract

Objectives : Alcoholic fatty liver is an early and reversible consequence of excessive alcohol consumption. The initial hepatocyte cell death stimulates subsequent inflammatory responses, leading to further liver injury and fibrosis. The objective of this study is to investigate the effects of Injinsaryung-san extract on the alcoholic fatty liver by chronic EtOH administration. Method : Male Sprague Dawley rats were used in this study. All animals were randomly divided into Normal group, treated with saline (n=10); EtOH group, treated with ethanol (n=10); EtOH+IS group, treated with ethanol+Injinsaryung-san extract (n=10). For oral administration of ethanol in Control and Sample group, the ethanol was dissolved in distilled water in concentrations of 25%(v/v). Throughout the experiment of 8 week, the rats were allowed free access to water and standard chow. Sample group were administrated by Injinsaryung-san extract daily for 8 weeks. Results : The levels of hepatic marker such as aspartate aminotransferase and alanine aminotransferase were altered. Histopathological changes were reduced and the expression of tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$) was markedly attenuated by Injinsaryung-san extract. Conclusion : These data suggest that Injinsaryung-san extract could be effective in protecting the liver from alcoholic fatty liver. The hepatoprotective mechanisms of Injinsaryung-san may be related to attenuation of $TNF-{\alpha}$ protein, as well as to the inhibition of inflammatory response in the liver. Therefore, Injinsaryung-san can be a candidate to protect against alcoholic fatty liver.

Keywords

References

  1. Baraona E, Lieber CS. Effects of ethanol on lipid metabolism. J Lipid Res. 1979;20(3): 289-315.
  2. Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol. 2017;23(36):6549-70. https://doi.org/10.3748/wjg.v23.i36.6549
  3. Chacko KR, Reinus J. Spectrum of Alcoholic Liver Disease. Clin Liver Dis. 2016;20(3): 419-27 https://doi.org/10.1016/j.cld.2016.02.002
  4. An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012;86(9): 1337-48. https://doi.org/10.1007/s00204-012-0814-6
  5. Yang W, Huang L, Gao J, Wen S, Tai Y, Chen M, Huang Z, Liu R, Tang C, Li J. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism. Mol Med Rep. 2017;16(4): 5225-34. https://doi.org/10.3892/mmr.2017.7295
  6. Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med. 2013; 65:1238-45. https://doi.org/10.1016/j.freeradbiomed.2013.09.009
  7. Pyo IJ, Lee JH, Woo HJ, Kim BW. Effects of Injinsaryung-san on Experimental Liver Damage in Rats. J Korean Oriental Med. 1995;16(2): 281-98.
  8. Ko H, Lee JH, Woo HJ. The Effects of 5 kinds of Injinsaryung-San fractions on Cell Viability, Cell Cycle Progression and Fas-mediated Apoptosis of HepG2 Cells. J Korean Oriental Med. 2000;21(3):174-85.
  9. Jang KS, Baik TH, Ha JY. Effects of Bojungikkitanghapinjinsaryungsan on rat liver injured by $CCl_4$. Korean J. Oriental Medical Pathology. 1997;11(1):12-20.
  10. Yun KS, Woo HJ, Lee JH, Kim YC. Effect of Injinchunggan-tang & Injinsaryung-san on NASH induced by MCD-diet in A/J mice. Korean J. Orient. Int. Med. 2009;30(2): 410-21.
  11. Lee JH, Park SM, Kim YC, Woo HJ. Clinical Study of the Effects of Chungganhaeju-tang on Alcoholic Fatty Liver. J Korean Oriental Med. 2001;22(4):107-13.
  12. Kim JJ, Seo BI, Choi HS, Kim SM, Woo CH, Koo JS, Park GY. Preventive Effects of Daekumeumja on Fatty Degeneration of Liver and Immunosuppression Induced by Alcohol. Korean J Oriental Medicine. 2010;16(2):167-79.
  13. Macieira MS, Almeida WG, Silva EA, Schenberg LC, Nakamura-Palacios EM. Alcohol dependenceinduced in rats by semivoluntary intermittent intake. Braz J Med Biol Res. 1997;30(9):1107-11. https://doi.org/10.1590/S0100-879X1997000900009
  14. Larue-Achagiotis C, Poussard AM, Louis-Sylvestre J. Alcohol drinking, food and fluidintakes and body weight gain in rats. Physiol Behav. 1990;47(3):545-8. https://doi.org/10.1016/0031-9384(90)90124-M
  15. Adeneye AA. Benebo AS. Oral metformin-ascorbic acid co-administration ameliorates alcohol-induced hepatotoxicity in rats. Nig Q J Hosp Med. 2007;17:155-9.
  16. Faremi TY. Suru SM. Fafunso MA. Obioha UE. Hepatoprotective potentials of Phyllanthusamarus against ethanol-induced oxidative stress in rats. Food Chem Toxicol. 2008;46:2658-64. https://doi.org/10.1016/j.fct.2008.04.022
  17. Herlong HF. Approach to the patient with abnormal liver enzymes. Hosp Pract. 1994; 29(11):32-8. https://doi.org/10.1080/21548331.1994.11443103
  18. McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016;15:817-28.
  19. Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005;21(3):323-30.
  20. Poullis A, Mendall MA. Alcohol, obesity, and TNF-alpha. Gut. 2001;49(2):313-4. https://doi.org/10.1136/gut.49.2.313
  21. Altamirano-Barrera A, Uribe M, Chavez-Tapia NC, Nuno-Lambarri N. The role of the gut microbiota in the pathology and prevention of liver disease. J Nutr Biochem. 2018;60:1-8. https://doi.org/10.1016/j.jnutbio.2018.03.006
  22. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology. 1999;117(4):942-52. https://doi.org/10.1016/S0016-5085(99)70354-9
  23. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 1990;14(2):255-9. https://doi.org/10.1111/j.1530-0277.1990.tb00482.x
  24. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 2004;34(1):9-19. https://doi.org/10.1016/j.alcohol.2004.07.008
  25. French JB, Bonacini M, Ghabril M, Foureau D, Bonkovsky HL. Hepatotoxicity Associated with the Use of Anti-TNF-${\alpha}$ Agents. Drug Saf. 2016;39(3):199-208. https://doi.org/10.1007/s40264-015-0366-9